[Gnumed-devel] address@hidden: [e-drug] "Poly-pills" set for launch in India]

[Karsten Hilbert]

Relevant to what we discussed when designing GNUmed
medication support:

----- Forwarded message from "Kaplan, Warren" <address@hidden> -----

> Subject: [e-drug] "Poly-pills"  set for launch in India
> 
> E-DRUG: "Poly-pills"  set for launch in India
> ---------------------------------------------
> 
> As summarized in the WHO Report "Priority Medicines for Europe and the
> World" (See
> http://archives.who.int/prioritymeds/report/final18october.pdf), the
> combination of several well established, widely used therapies into a
> single medication ( a "poly-pill")  to prevent stroke and heart attack
> has been discussed since at least 2003 with the provocative paper by
> Wald and Law (British Medical Journal, 2003: 326: 1419-1425). While the
> subsequent discussion of this paper focussed on whether doctors and
> patients would be ready for such poly-pharmacy, the Priority Medicines
> Report highlighted the untapped potential of such therapies for
> prevention of cardiovascular disease. 
> 
> I would like to bring to the attention of e-drug readers two very
> important developments in public health, both related to the
> 'poly-pill'.  
>  
> 1. Cadila, has launched a five-in-one "polypill" in India. See 
> http://timesofindia.indiatimes.com/news/business/india-business/Cadila-l
> aunches-5-in-1-polypill/articleshow/4930765.cms [repair link]
>  
> According to this press release, "After the domestic launch, Cadila is
> planning to launch ...  globally for which dossiers are being prepared
> and will be submitted for registration in a couple of months to
> authorities in nearly 45 countries."
>  
> It is hoped that the cost of the pill will put it into the range that
> would be affordable to at least the Indian middle class. 
>  
> 2. Dr. Reddy's is set to launch in India in December a polypill
> containing aspirin, a statin, a beta blocker and an ACE inhibitor. 
>  
> http://www.dnaindia.com/money/report_reddy-s-sets-heart-pill-for-dec-lau
> nch_1276413 [repair link]
>  
> The Dr. Reddy's product is clearly aimed at secondary prevention, i.e.
> after a heart attack.
>  
> Both these achievements have the potential for being significant
> advances in global public health.
>  
> Warren A. Kaplan, PhD, JD, MPH
> Center for International Health & Development
> Boston University School of Public Health
> 801 Massachusetts Avenue
> Boston, MA 02118
> ph: + 617 414 1152
> address@hidden 
> 
> _______________________________________________
> Post message: address@hidden
> Subscribe: address@hidden
> Unsubscribe: address@hidden
> Help: address@hidden
> Info & archives: http://list.healthnet.org/mailman/listinfo/e-drug

----- End forwarded message -----

-- 
GPG key ID E4071346 @ wwwkeys.pgp.net
E167 67FD A291 2BEA 73BD  4537 78B9 A9F9 E407 1346